South Korea’s Samsung Biologics signs $231 million supply deal with GSK
[ad_1] SEOUL (Reuters) – South Korean contract drugs manufacturer Samsung Biologics Co Ltd said on Friday it had signed a
Read more
231
[ad_1] SEOUL (Reuters) – South Korean contract drugs manufacturer Samsung Biologics Co Ltd said on Friday it had signed a
Read more